VisiRose
Business Services · Tennessee, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
800 S Gay St Ste 1610, Knoxville, Tennes...Phone Number
(866) 216-7333Website
www.visirose.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About VisiRose
VisiRose is a startup biotechnology company of the University of Miami and Provectus Biopharmaceuticals, focused on commercializing the Miller School of Medicines Bascom Palmer Eye Institute and its Ophthalmic Biophysics Centers innovative ocular research using bioactive synthetic small molecule rose bengal.Explore more
VisiRose Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is VisiRose your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if VisiRose is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at VisiRose
Check if VisiRose has recently received funding, and reach out quickly before it becomes old news!
VisiRose, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on VisiRose recently announced quarterly report
Funding: Get notified immidiatlly once VisiRose has new funding data
Product Launch: Get notified when VisiRose launches new products
Click to see if VisiRose had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined VisiRose as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
VisiRose is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
VisiRose is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about VisiRose.
VisiRose financials insights
Gather financial insights about VisiRose, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2025
Angel/Seed
$3M
VisiRose Tech Stack
A closer look at the technologies used by VisiRose
See more technologies
VisiRose News & Media
Provectus Biopharmaceuticals and VisiRose Announce U.S. Patent Award for Light-Independent Antibacterial Eye Drop Targeting Drug-Resistant Ocular Infections
KNOXVILLE, Tenn., June 30, 2026 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT), a clinical-stage biotechnology company developing pharmaceutical grade rose bengal sodium (“RBS”) active pharmaceutical ingredient (“API”) as a platform therapeutic, and VisiRose, Inc. (“VisiRose”), Provectus’s clinical-stage ophthalmology subsidiary, today announced the issuance of U.S. Patent No. 12,661,335, titled “Halogenated Xanthene-Containing Topical Anti-GrBascom Palmer Eye Institute Presents Four Posters on Rose Bengal Photodynamic Antimicrobial Therapy at ARVO 2026, Advancing the Clinical Case for Provectus’s VisiRose Subsidiary and Rose Bengal Sodium in Infectious Keratitis
KNOXVILLE, Tenn., May 04, 2026 (GLOBE NEWSWIRE) -- Provectus Biopharmaceuticals, Inc. (“Provectus” or the “Company”) (OTCQB: PVCT), a clinical-stage biopharmaceutical company developing proprietary synthetic small molecule rose bengal sodium (“RBS”)-based medicines, notes that researchers from Bascom Palmer Eye Institute (“BPEI”) at the University of Miami will present four posters on rose bengal photodynamic antimicrobial therapy (“RB-PDAT”) at the 2026 Annual Meeting of the Association for Res
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding VisiRose
Sign Up For FreeTo access detailed company insights
VisiRose is a startup biotechnology company of the University of Miami and Provectus Biopharmaceuticals, focused on commercializing the Miller School of Medicines Bascom Palmer Eye Institute and its Ophthalmic Biophysics Centers innovative ocular research using bioactive synthetic small molecule rose bengal.... Read More
